Search

Search Constraints

You searched for: Author/Creator Ratner, Nancy

Search Results

1. 2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. Issue 5 (21st April 2018)

3. Author Correction: AMP kinase promotes glioblastoma bioenergetics and tumour growth. Issue 11 (November 2018)

5. Conditional Inactivation of Pten with EGFR Overexpression in Schwann Cells Models Sporadic MPNST. (18th December 2012)

6. Corrigendum to "The Learning Disabilities Network (LeaDNet): Using Neurofibromatosis Type 1 [NF1] as a Paradigm for Translational Research"1. Issue 1 (24th December 2012)

7. CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies. Issue 3 (17th January 2014)

8. Defective transcription elongation in a subset of cancers confers immunotherapy resistance. Issue 1 (December 2018)

9. First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeutics. Issue 6 (25th March 2019)

10. HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat. (5th February 2016)